1UMO | B:23-132; B:23-132 | THE CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN MAN |
1URV | B:23-132; B:23-132 | CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN MAN DISPLAYS HEME HEXA-COORDINATION |
1URY | B:23-132; B:23-132 | CYTOGLOBIN CAVITIES |
1UT0 | B:23-132; B:23-132 | CRYSTAL STRUCTURE OF CYTOGLOBIN: THE FOURTH GLOBIN TYPE DISCOVERED IN MAN DISPLAYS HEME HEXA-COORDINATION |
1V5H | A:23-132 | CRYSTAL STRUCTURE OF HUMAN CYTOGLOBIN (FERRIC FORM) |
1JEB | C:6-106; C:6-106 | CHIMERIC HUMAN/MOUSE CARBONMONOXY HEMOGLOBIN (HUMAN ZETA2 / MOUSE BETA2) |
1JY7 | W:6-106; W:6-106; W:6-106; W:6-106; W:6-106; W:6-106; X:7-111; X:7-111; X:7-111; X:7-111; X:7-111; X:7-111 | THE STRUCTURE OF HUMAN METHEMOGLOBIN. THE VARIATION OF A THEME |
1K0Y | C:406-506; C:406-506; D:607-711; D:607-711 | X-RAY CRYSTALLOGRAPHIC ANALYSES OF SYMMETRICAL ALLOSTERIC EFFECTORS OF HEMOGLOBIN. COMPOUNDS DESIGNED TO LINK PRIMARY AND SECONDARY BINDING SITES |
1KD2 | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTAL STRUCTURE OF HUMAN DEOXYHEMOGLOBIN IN ABSENCE OF ANY ANIONS |
1LFL | R:6-106; R:6-106; R:6-106; R:6-106; S:7-111; S:7-111; S:7-111; S:7-111 | DEOXY HEMOGLOBIN (90% RELATIVE HUMIDITY) |
1LFQ | A:6-106; B:7-111 | OXY HEMOGLOBIN (93% RELATIVE HUMIDITY) |
1LFT | A:6-106; B:7-111 | OXY HEMOGLOBIN (90% RELATIVE HUMIDITY) |
1LFV | A:6-106; B:7-111 | OXY HEMOGLOBIN (88% RELATIVE HUMIDITY) |
1LFZ | A:6-106; B:7-111 | OXY HEMOGLOBIN (25% METHANOL) |
1LJW | A:6-106; B:7-111 | CRYSTAL STRUCTURE OF HUMAN CARBONMONOXY HEMOGLOBIN AT 2.16 A: A SNAPSHOT OF THE ALLOSTERIC TRANSITION |
1MKO | C:6-106; C:6-106; D:7-111; D:7-111 | A FOURTH QUATERNARY STRUCTURE OF HUMAN HEMOGLOBIN A AT 2.18 A RESOLUTION |
1NEJ | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTALLINE HUMAN CARBONMONOXY HEMOGLOBIN S (LIGANDED SICKLE CELL HEMOGLOBIN) EXHIBITS THE R2 QUATERNARY STATE AT NEUTRAL PH IN THE PRESENCE OF POLYETHYLENE GLYCOL: THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE |
1NQP | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTAL STRUCTURE OF HUMAN HEMOGLOBIN E AT 1.73 A RESOLUTION |
1O1I | A:6-106; B:7-111 | CYANOMET HEMOGLOBIN (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W) |
1O1J | A:148-248; D:7-111; D:7-111 | DEOXY HEMOGLOBIN (A-GLY-C:V1M,L29F,H58Q; B,D:V1M,L106W) |
1O1K | C:6-106; C:6-106; D:7-111; D:7-111 | DEOXY HEMOGLOBIN (A,C:V1M; B,D:V1M,V67W) |
1O1L | A:148-248; D:7-111; D:7-111 | DEOXY HEMOGLOBIN (A-GLY-C:V1M,L29W,H58Q; B,D:V1M) |
1O1M | A:150-250; D:7-111; D:7-111 | DEOXY HEMOGLOBIN (A-GLYGLYGLY-C:V1M,L29F,H58Q B,D:V1M,V67W) |
1O1N | A:150-250; D:7-111; D:7-111 | DEOXY HEMOGLOBIN (A-GLYGLYGLY-C:V1M,L29W; B,D:V1M) |
1QSH | C:6-106; C:6-106; D:7-111; D:7-111 | MAGNESIUM(II)-AND ZINC(II)-PROTOPORPHYRIN IX'S STABILIZE THE LOWEST OXYGEN AFFINITY STATE OF HUMAN HEMOGLOBIN EVEN MORE STRONGLY THAN DEOXYHEME |
1QSI | C:6-106; C:6-106; D:7-111; D:7-111 | MAGNESIUM(II)-AND ZINC(II)-PROTOPORPHYRIN IX'S STABILIZE THE LOWEST OXYGEN AFFINITY STATE OF HUMAN HEMOGLOBIN EVEN MORE STRONGLY THAN DEOXYHEME |
1QXD | C:6-106; C:6-106; D:7-111; D:7-111 | STRUCTURAL BASIS FOR THE POTENT ANTISICKLING EFFECT OF A NOVEL CLASS OF 5-MEMBERED HETEROCYCLIC ALDEHYDIC COMPOUNDS |
1QXE | C:6-106; C:6-106; D:7-111; D:7-111 | STRUCTURAL BASIS FOR THE POTENT ANTISICKLING EFFECT OF A NOVEL CLASS OF 5-MEMBERED HETEROCYCLIC ALDEHYDIC COMPOUNDS |
1R1X | A:6-106; B:7-111 | CRYSTAL STRUCTURE OF OXY-HUMAN HEMOGLOBIN BASSETT AT 2.15 ANGSTROM |
1R1Y | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTAL STRUCTURE OF DEOXY-HUMAN HEMOGLOBIN BASSETT AT 1.8 ANGSTROM |
1RPS | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN HEMOGLOBIN. HEMOGLOBIN EXPOSED TO NO UNDER ANEROBIC CONDITIONS |
1RQ3 | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN DEOXYHEMOGLOBIN, DEOXYHEMOGLOBIN |
1RQ4 | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN HEMOGLOBIN, HEMOGLOBIN EXPOSED TO NO UNDER AEROBIC CONDITIONS |
1RQA | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTALLOGRAPHIC ANALYSIS OF THE INTERACTION OF NITRIC OXIDE WITH QUATERNARY-T HUMAN HEMOGLOBIN. BETA W73E HEMOGLOBIN EXPOSED TO NO UNDER ANAEROBIC CONDITIONS |
1RVW | A:6-106; B:7-111 | R STATE HUMAN HEMOGLOBIN [ALPHA V96W], CARBONMONOXY |
1SDK | C:6-106; C:6-106; D:7-111; D:7-111 | CROSS-LINKED, CARBONMONOXY HEMOGLOBIN A |
1SDL | C:6-106; C:6-106; D:7-111; D:7-111 | CROSS-LINKED, CARBONMONOXY HEMOGLOBIN A |
1SHR | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTAL STRUCTURE OF FERROCYANIDE BOUND HUMAN HEMOGLOBIN A2 AT 1.88A RESOLUTION |
1SI4 | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTAL STRUCTURE OF HUMAN HEMOGLOBIN A2 (IN R2 STATE) AT 2.2 A RESOLUTION |
1THB | C:6-106; C:6-106; D:7-111; D:7-111 | REFINEMENT OF A PARTIALLY OXYGENATED T STATE HAEMOGLOBIN AT 1.5 ANGSTROMS RESOLUTION |
1UIW | G:6-106; G:6-106; G:6-106; G:6-106; H:7-111; H:7-111; H:7-111; H:7-111 | CRYSTAL STRUCTURES OF UNLIGANDED AND HALF-LIGANDED HUMAN HEMOGLOBIN DERIVATIVES CROSS-LINKED BETWEEN LYS 82BETA1 AND LYS 82BETA2 |
1VWT | C:6-106; C:6-106; D:7-111; D:7-111 | T STATE HUMAN HEMOGLOBIN [ALPHA V96W], ALPHA AQUOMET, BETA DEOXY |
1XXT | C:6-106; C:6-106; D:7-111; D:7-111 | THE T-TO-T HIGH TRANSITIONS IN HUMAN HEMOGLOBIN: WILD-TYPE DEOXY HB A (LOW SALT, ONE TEST SET) |
1XY0 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAK40G DEOXY LOW-SALT |
1XZ2 | C:6-106; C:6-106; D:7-111; D:7-111 | WILD-TYPE HEMOGLOBIN DEOXY NO-SALT |
1XZ5 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAL91A DEOXY LOW-SALT |
1XZ7 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAR92A DEOXY LOW-SALT |
1XZU | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAD94G DEOXY LOW-SALT |
1Y01 | B:6-106 | CRYSTAL STRUCTURE OF AHSP BOUND TO FE(II) ALPHA-HEMOGLOBIN |
1Y09 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAN97A DEOXY LOW-SALT |
1Y0C | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAY140F DEOXY LOW-SALT |
1Y0D | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: DESARG141ALPHA DEOXY LOW-SALT |
1Y0T | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV1M DEOXY LOW-SALT (1 TEST SET) |
1Y0W | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV1M DEOXY LOW-SALT (10 TEST SETS) |
1Y22 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV33A DEOXY LOW-SALT (1 TEST SET) |
1Y2Z | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV34G DEOXY LOW-SALT (1 TEST SET) |
1Y31 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35A DEOXY LOW-SALT (1 TEST SET) |
1Y35 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35F DEOXY LOW-SALT (1 TEST SET) |
1Y45 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP36A DEOXY LOW-SALT (10 TEST SETS) |
1Y46 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37Y DEOXY LOW-SALT (10 TEST SETS) |
1Y4B | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37H DEOXY LOW-SALT (10 TEST SETS) |
1Y4G | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37G DEOXY LOW-SALT (10 TEST SETS) |
1Y4P | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37E DEOXY LOW-SALT (10 TEST SETS) |
1Y4Q | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAF42A DEOXY LOW-SALT (1 TEST SET) |
1Y4R | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAF45A DEOXY LOW-SALT (1 TEST SET) |
1Y4V | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAC93A DEOXY LOW-SALT (1 TEST SET) |
1Y5F | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAL96A DEOXY LOW-SALT (1 TEST SET) |
1Y5J | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAH97A DEOXY LOW-SALT (1 TEST SET) |
1Y5K | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAD99A DEOXY LOW-SALT (10 TEST SETS) |
1Y7C | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP100A DEOXY LOW-SALT (1 TEST SET) |
1Y7D | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP100G DEOXY LOW-SALT (1 TEST SET) |
1Y7G | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAN102A DEOXY LOW-SALT (1 TEST SET) |
1Y83 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY145G DEOXY LOW-SALT (1 TEST SET) |
1Y8W | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: ALPHAR92A OXY (2MM IHP, 20% PEG) (10 TEST SETS) |
1YE0 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAV33A OXY (2MM IHP, 20% PEG) (1 TEST SET) |
1YE1 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35A OXY (2MM IHP, 20% PEG) (1 TEST SET) |
1YE2 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAY35F OXY (2MM IHP, 20% PEG) (1 TEST SET) |
1YEN | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP36A OXY (2MM IHP, 20% PEG) (10 TEST SETS) |
1YEO | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37A OXY (10 TEST SETS) |
1YEU | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37G OXY (10 TEST SETS) |
1YEV | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37E OXY (10 TEST SETS) |
1YFF | G:6-106; G:6-106; G:6-106; G:6-106; H:7-111; H:7-111; H:7-111; H:7-111 | STRUCTURE OF HUMAN CARBONMONOXYHEMOGLOBIN C (BETA E6K): TWO QUATERNARY STATES (R2 AND R3) IN ONE CRYSTAL |
1YG5 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37H OXY (2MM IHP, 20% PEG) (10 TEST SETS) |
1YGD | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37E ALPHA ZINC BETA OXY (10 TEST SETS) |
1YGF | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAH97A OXY (2MM IHP, 20% PEG) (1 TEST SET) |
1YH9 | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: HBA OXY (2MM IHP, 20% PEG) (10 TEST SETS) |
1YHE | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: HBA OXY (5.0MM IHP, 20% PEG) (10 TEST SETS) |
1YHR | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: HBA OXY (10.0MM IHP, 20% PEG) (10 TEST SETS) |
1YIE | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-THIGH QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAW37A OXY (2.2MM IHP, 13% PEG) (1 TEST SET) |
1YIH | C:6-106; C:6-106; D:7-111; D:7-111 | T-TO-T(HIGH) QUATERNARY TRANSITIONS IN HUMAN HEMOGLOBIN: BETAP100A OXY (2.2MM IHP, 20% PEG) (1 TEST SET) |
1YVQ | C:6-106; C:6-106; D:7-111; D:7-111 | THE LOW SALT (PEG) CRYSTAL STRUCTURE OF CO HEMOGLOBIN E (BETAE26K) APPROACHING PHYSIOLOGICAL PH (PH 7.5) |
1YVT | A:6-106; B:7-111 | THE HIGH SALT (PHOSPHATE) CRYSTAL STRUCTURE OF CO HEMOGLOBIN E (GLU26LYS) AT PHYSIOLOGICAL PH (PH 7.35) |
1YZI | A:6-106; B:7-111 | A NOVEL QUATERNARY STRUCTURE OF HUMAN CARBONMONOXY HEMOGLOBIN |
1Z8U | D:6-106; D:6-106 | CRYSTAL STRUCTURE OF OXIDIZED ALPHA HEMOGLOBIN BOUND TO AHSP |
2W6V | C:6-106; C:6-106; D:7-111; D:7-111 | STRUCTURE OF HUMAN DEOXY HEMOGLOBIN A IN COMPLEX WITH XENON |
2W72 | C:6-106; C:6-106; D:7-111; D:7-111 | DEOXYGENATED STRUCTURE OF A DISTAL SITE HEMOGLOBIN MUTANT PLUS XE |
3KMF | E:406-506; E:406-506; G:607-711; G:607-711 | ROOM TEMPERATURE TIME-OF-FLIGHT NEUTRON DIFFRACTION STUDY OF DEOXY HUMAN NORMAL ADULT HEMOGLOBIN |
3NL7 | A:6-106; B:7-111 | HUMAN HEMOGLOBIN A MUTANT BETA H63W CARBONMONOXY-FORM |
3NMM | C:6-106; C:6-106; D:7-111; D:7-111 | HUMAN HEMOGLOBIN A MUTANT ALPHA H58W DEOXY-FORM |
3P5Q | A:6-106; B:7-111 | FERRIC R-STATE HUMAN AQUOMETHEMOGLOBIN |
3QJB | A:6-106; B:7-111 | HUMAN HEMOGLOBIN A MUTANT ALPHA H58L CARBONMONOXY-FORM |
3QJC | A:6-106; B:7-111 | HUMAN HEMOGLOBIN A MUTANT BETA H63L CARBONMONOXY-FORM |
3QJD | C:6-106; C:6-106; D:7-111; D:7-111 | HUMAN HEMOGLOBIN A MUTANT ALPHA H58L DEOXY-FORM |
3QJE | C:6-106; C:6-106; D:7-111; D:7-111 | HUMAN HEMOGLOBIN A MUTANT BETA H63L DEOXY-FORM |
3R5I | C:6-106; C:6-106; D:7-111; D:7-111 | CRYSTAL STRUCTURE OF LIGANDED HEMOGLOBIN COMPLEXED WITH A POTENT ANTISICKLING AGENT, INN-312 |
3RGK | A:6-112 | CRYSTAL STRUCTURE OF HUMAN MYOGLOBIN MUTANT K45R |
1OJ6 | D:5-114; D:5-114; D:5-114; D:5-114 | HUMAN BRAIN NEUROGLOBIN THREE-DIMENSIONAL STRUCTURE |